Impact Factor 2023

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity

Y. Emad, T. Gheita, H. Darweesh, P. Klooster, R. Gamal, H. Fathi, N. El-Shaarawy, M. Gamil, M. Hawass, R.M. El-Refai, H. Al-Hanafi, S. Abd-Ellatif, A. Ismail, J. Rasker

85-91

06-07-2018

https://doi.org/10.4081/reumatismo.2018.1027

2583

PDF: 1296
Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio

E. Cipriano, F. Ceccarelli, L. Massaro, F. R. Spinelli, C. Alessandri, C. Perricone, G. Valesini, F. Conti

62-67

16-09-2015

https://doi.org/10.4081/reumatismo.2015.828

2522

PDF: 1131
Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus

L. Iaccarino, A. Ghirardello, M. Zen, D. Villalta, A. Tincani, L. Punzi, A. Doria

314-320

11-12-2012

https://doi.org/10.4081/reumatismo.2012.314

2443

PDF: 1224
Typing TREX1 gene in patients with systemic lupus erythematosus

M. Fredi, M. Bianchi, L. Andreoli, G. Greco, I. Olivieri, S. Orcesi, E. Fazzi, C. Cereda, A. Tincani

1-7

30-06-2015

https://doi.org/10.4081/reumatismo.2015.782

3173

PDF: 1682
Anti-dsDNA negative and anti-Ro positive lupus nephritis: a report of a rare case

D. Jain, H.K. Aggarwal, V. Kaverappa, S. Dhayia, P. Jain, S. Yadav

302-306

17-03-2014

https://doi.org/10.4081/reumatismo.2013.706

4730

PDF: 1304
Urinary CXCL10: a marker of nephritis in lupus patients

M. A. Marie, R. E. Abu Khalil, H. M. Habib

292-297

17-03-2014

https://doi.org/10.4081/reumatismo.2013.719

2873

PDF: 1642
Short story of antirheumatic therapy.VIII. The immunodepressants

G. Pasero, P. Marson

44-54

19-03-2012

https://doi.org/10.4081/reumatismo.2012.44

1538

PDF: 1469
Systemic lupus erythematosus presenting as fulminant lupus pneumonitis: a rare case report

H.K. Aggarwal, D. Jain, A. Mittal, A. Rao, R.K. Yadav, P. Jain

48-52

23-06-2016

https://doi.org/10.4081/reumatismo.2016.846

2842

PDF: 1648
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?

M. Taraborelli, F. Inverardi, M. Fredi, A. Ceribelli, I. Cavazzana, A. Tincani, F. Franceschini

321-325

11-12-2012

https://doi.org/10.4081/reumatismo.2012.321

1798

PDF: 1207
Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre

A. Bortoluzzi, M. Padovan, I. Farina, E. Galuppi, F. De Leonardis, M. Govoni

350-359

20-12-2012

https://doi.org/10.4081/reumatismo.2012.350

3062

PDF: 2621
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus

M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani

137-143

16-12-2016

https://doi.org/10.4081/reumatismo.2016.891

2176

PDF: 1300
Pain and systemic lupus erythematosus

M. Di Franco, M.P. Guzzo, F.R. Spinelli, F. Atzeni, P. Sarzi-Puttini, F. Conti, C. Iannuccelli

33-38

06-06-2014

https://doi.org/10.4081/reumatismo.2014.762

5116

PDF: 2723
Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center

F. Dall'Ara, I. Cavazzana, M. Frassi, M. Taraborelli, M. Fredi, F. Franceschini, L. Andreoli, M. Rossi, C. Cattaneo, A. Tincani, P. Airò

100-105

06-07-2018

https://doi.org/10.4081/reumatismo.2018.1023

2365

PDF: 1405
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series

E. Chessa, M. Piga, A. Floris, A. Mathieu, A. Cauli

175-183

21-12-2017

https://doi.org/10.4081/reumatismo.2017.1007

3268

PDF: 1701
Systemic vasculitis in a patient with rhupus syndrome

O. Zengin, M. E. Onder, M. A. Sarica, I. H. Turkbeyler, G. Kimyon, Z. H. Demir, H. Yildiz, B. Kisacik, A. M. Onat

161-164

23-05-2016

https://doi.org/10.4081/reumatismo.2015.858

1832

PDF: 1021
Spontaneous soft tissue haemorrhage in systemic lupus erythematosus

M.C. Abdulla

199-202

31-12-2016

https://doi.org/10.4081/reumatismo.2016.952

1787

PDF: 843
Diagnostic utility of serum melatonin levels in systemic lupus erythematosus: a case-control study

A.B. Rasheed, M.S. Daoud, F.I. Gorial

170-174

21-12-2017

https://doi.org/10.4081/reumatismo.2017.998

1748

PDF: 768
Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant

N. Bassi, R. Luisetto, A. Ghirardello, M. Gatto, B. Bottazzi, Y. Shoenfeld, L. Punzi, A. Doria

380-387

20-12-2012

https://doi.org/10.4081/reumatismo.2012.380

2303

PDF: 952
Osteoporosis and rheumatic diseases

N. Maruotti, A. Corrado, F.P. Cantatore

125-135

28-06-2014

https://doi.org/10.4081/reumatismo.2014.785

8092

PDF: 3415
Temporomandibular joint dysfunction in various rheumatic diseases

F.J. Aceves-Avila, M. Chávez-López, J.R. Chavira-González, C. Ramos-Remus

126-130

24-07-2013

https://doi.org/10.4081/reumatismo.2013.126

4048

PDF: 1426
The association between serum prolactin levels and interleukin-6 and systemic lupus erythematosus activity

W.A. Wan Asyraf, M.S. Mohd Shahrir, W. Asrul, A.W. Norasyikin, O. Hanita, W.Y. Kong, M.T. Azmi

241-250

20-12-2018

https://doi.org/10.4081/reumatismo.2018.1075

1596

PDF: 964
A rare form of anemia in systemic lupus erythematosus

C.A. Mansoor, R. Narayan

119-121

21-09-2017

https://doi.org/10.4081/reumatismo.2017.982

2945

PDF: 988
Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

C. Nalli, L. Andreoli, M. Motta, G.L. Norman, Z. Shums, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, A. Meini, V. Medeghini, T. Avcin, P.L. Meroni, A. Tincani

91-96

https://doi.org/10.4081/reumatismo.2011.91

1187

PDF: 724
The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases

P. Quattrocchi, A. Barrile, D. Bonanno, L. Giannetto, M. Patafi, V. Tigano, B. Ferlazzo

109-113

https://doi.org/10.4081/reumatismo.2005.109

980

PDF: 3785
Clinical profile of patients with lupus psychosis in a Colombian cohort

M. Muñoz-Urbano, J. Sánchez-Bautista, A. Ramirez, D.C. Quintero-González, Y. Santamaria-Alza, A.L. Vanegas-García

13-09-2022

https://doi.org/10.4081/reumatismo.2022.1483

1324

PDF: 661
Epidemiology and demographics of cutaneous lupus erythematosus in Colombia between 2015 and 2019

D.G. Fernández Ávila, M. Rivera Maldonado, L.P. Charry Anzola

08-05-2023

https://doi.org/10.4081/reumatismo.2023.1568

1323

PDF: 929
Quality of life measures in systemic lupus erythematosus: a systematic review

M. Radin, G. El Hasbani, A. Barinotti, D. Roccatello, I. Uthman, A. Taher, S. Sciascia

07-02-2022

https://doi.org/10.4081/reumatismo.2021.1447

7539

PDF: 1688
Drug-induced lupus erythematosus

F. Atzeni, M.G. Marrazza, P. Sarzi-Puttini, M. Carrabba

147-154

https://doi.org/10.4081/reumatismo.2003.147

7282

PDF: 18170
Visceral muscle dysmotility syndrome in systemic lupus erythematosus: which is the role of 18 fluorodeoxyglucose-positron emission tomography-computed tomography? A clinical case and literature review

S. Scriffignano, F.M. Perrotta, M. Ricci, B. Carabellese, E. Lubrano

24-09-2024

https://doi.org/10.4081/reumatismo.2024.1647

652

PDF: 145
Clinical profile of patients with lupus nephritis

T.L. Skare, A.C. Schönrock

316-317

https://doi.org/10.4081/reumatismo.2009.316

969

PDF: 666
Severe bullous systemic lupus erythematosus successfully treated with low dose rituximab: a case report from sub-Saharan Africa

A.A. Akpabio, B.I. Otike-Odibi

115-119

23-07-2020

https://doi.org/10.4081/reumatismo.2020.1274

1048

PDF: 631
Clinical features and genetic biomarkers associated with different phenotypes of systemic lupus erythematosus in Paraguayan patients

I. Acosta-Colman, Z. Morel, A. Ayala Lugo, V. Jolly, I. de Guillén, P. Langjahr, M. Vazquez, M.T Martínez de Filártiga, M.E. Acosta

17-07-2023

https://doi.org/10.4081/reumatismo.2023.1541

955

PDF: 568
Occurrence of Hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis

L. Carli, C. Tani, S. Vagnani, F. Querci, C. Baldini, R. Talarico, A. Della Rossa, S. Bombardieri, M. Mosca

203-204

31-10-2013

https://doi.org/10.4081/reumatismo.2013.203

2611

PDF: 669

Appendix: 318
Systemic lupus erythematosus induced by anti-tumor necrosis factor α therapy in inflammatory rheumatic diseases: a case series

D. Oliveira, A. Martins, F. Martins, C. Gomes, S. Pimenta, C. Vaz, L. Costa, M. Bernardes

24-09-2024

https://doi.org/10.4081/reumatismo.2024.1658

795

PDF: 190
Macrophage activation syndrome in a patient with systemic lupus erythematosus undergoing cyclophosphamide treatment: a case report

L. Fioravante da Silveira, A. Zago, D. Zanchet, D. Chemello

17-07-2023

https://doi.org/10.4081/reumatismo.2023.1597

1080

PDF: 628
Unmasking of systemic lupus erythematosus in a patient with hemophagocytic lymphohistiocytosis- macrophage activation syndrome (HLA-MAS) and diffuse alveolar hemorrhage

P. Sukhadiya, P. Kumar, D.S. Meena, A. Kumar P.H., N. Vijayan, P. Garg, M.K. Garg

21-03-2023

https://doi.org/10.4081/reumatismo.2022.1488

1322

PDF: 604
Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study

F. Ceccarelli, V. Covelli, G. Olivieri, F. Natalucci, C. Alessandri, F. Conti

13-09-2022

https://doi.org/10.4081/reumatismo.2022.1491

1083

PDF: 493
The history of antiphospholipid syndrome

A. Tincani, G. Fontana, C. Mackworth-Young

21-03-2023

https://doi.org/10.4081/reumatismo.2022.1556

2265

PDF: 1826
IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren’s syndrome

A. Alunno, O. Bistoni, E. Bartoloni Bocci, S. Caterbi, B. Bigerna, A. Pucciarini, A. Tabarrini, R. Mannucci, D. Beghelli, B. Falini, R. Gerli

192-198

31-10-2013

https://doi.org/10.4081/reumatismo.2013.192

3638

PDF: 920
Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study

A. Fayed, M.M. El Menyawi, M. Ghanema, O. Shaker, R. Elgohary

145-153

19-11-2020

https://doi.org/10.4081/reumatismo.2020.1308

975

PDF: 614
Systemic lupus erythematosus and infections

B.K. Singh, S. Singh

154-169

19-11-2020

https://doi.org/10.4081/reumatismo.2020.1303

4378

PDF: 2423
Rheumatic diseases in migrant patients resident in Tuscany: epidemiological data analysis and single-center experience

L. Cometi, P. Francesconi, B. Bellini, L. Turco, F. Voller, F. Nacci, S. Bellando-Randone, M. Matucci-Cerinic, S. Guiducci

22-03-2024

https://doi.org/10.4081/reumatismo.2024.1547

790

PDF: 441
The main stages in the history of systemic lupus erythematosus

M. Rampudda, P. Marson, G. Pasero

145-152

https://doi.org/10.4081/reumatismo.2009.145

1897

PDF: 1807
Ro60 and La ribonucleoproteins become self-aggregated by cell stress

S.H. Sánchez-Rodríguez, D. Herrera-van-Oostdam, E. Avalos-Díaz, R. Herrera-Esparza

292-298

https://doi.org/10.4081/reumatismo.2007.292

883

PDF: 809
Neuropsychiatric Lupus Erythematosus

M. Vadacca, F. Buzzulini, A. Rigon, G. Coppolino, A. Palma Modoni, R. Massa, A. Afeltra

177-186

https://doi.org/10.4081/reumatismo.2006.177

3823

PDF: 17106
Adherence to cervical cancer screening in an Italian SLE cohort

C. Tani, L. Carli, M. Mosca, C. Baldini, A. Consensi, M. Doveri, R. Talarico, S. Bombardieri

11-17

https://doi.org/10.4081/reumatismo.2011.11

1247

PDF: 780
Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR+CD25- cell subset in patients with systemic lupus erythematosus

A. Alunno, G. Nocentini, O. Bistoni, R. Bianchini, E. Bartoloni Bocci, C. Riccardi, R. Gerli

195-201

https://doi.org/10.4081/reumatismo.2010.195

1265

PDF: 835
Biclonal gammopathy of undetermined significance in a patient with systemic lupus erythematosus and antiphospholipid syndrome

V. Bruzzese, P. Scolieri, J. Pepe

07-02-2022

https://doi.org/10.4081/reumatismo.2021.1431

5685

PDF: 632
Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive?

L. Andreoli, F. Pregnolato, R.W. Burlingame, V. Fanelli, F. Allegri, A. Radice, C. Corace, R.A. Sinico, A. Tinconi, P.L. Meroni

185-191

https://doi.org/10.4081/reumatismo.2008.185

1121

PDF: 1071
BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity

M. Vadacca, D. Margiotta, D. Sambataro, F. Buzzulini, M. Lo Vullo, A. Rigon, A. Afeltra

259-265

https://doi.org/10.4081/reumatismo.2010.259

1868

PDF: 2067

1 - 50 of 77 items 1 2 > >>

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy